Q-Med has obtained registration approval for Restylane® in China

Q-Med has obtained registration approval for Restylane® in China. An application for sales approval will be submitted shortly and it is estimated that sales of the product will begin at the end of the second quarter in 2009.

“There is a large appetite for new things in China and great respect for products from the West. We are therefore very pleased about this registration approval, which means that Restylane® will be the first hyaluronic acid product intended for the cosmetic market in China”, says Bengt Ågerup, Q-Med´s President and CEO.